| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jackie Peter Burnett CEO | CNSX Exchange | CA75150G1046 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
RAMM Pharma Corp. is a pioneering firm specializing in the research and development, production, and sales of advanced cannabinoid pharmacology and formulations, alongside a broad spectrum of pharmaceuticals, cosmetics, and nutraceutical products. Initially founded in 1987 as MTC Growth Fund-I Inc., the company underwent a significant rebranding to RAMM Pharma Corp. in October 2019, marking a new era in its operational focus and strategic direction. Based in Toronto, Canada, RAMM Pharma extends its market reach across diverse geographies including Uruguay, Italy, and Poland, reflecting its global ambitions and the universal appeal of its product offerings. The company not only excels in the creation of innovative cannabinoid-based products but also diversifies its portfolio through the resale of medical supplies, as well as the sale of medical devices, consumables, and veterinarian products, showcasing its multifaceted approach to addressing various health and wellness needs.
Listed below are the prime categories of products and services offered by RAMM Pharma Corp., emphasizing the company’s commitment to delivering comprehensive health and wellness solutions: